<SEC-DOCUMENT>0001213900-25-127129-index.html : 20251231
<SEC-HEADER>0001213900-25-127129.hdr.sgml : 20251231
<ACCEPTANCE-DATETIME>20251231162503
ACCESSION NUMBER:		0001213900-25-127129
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE:		20251231
DATE AS OF CHANGE:		20251231
EFFECTIVENESS DATE:		20251231

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cadrenal Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001937993
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				880860746
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-568657
		FILM NUMBER:		251617698

	BUSINESS ADDRESS:	
		STREET 1:		822 A1A NORTH
		STREET 2:		SUITE 306
		CITY:			PONTE VEDRA
		STATE:			FL
		ZIP:			32082
		BUSINESS PHONE:		904-300-0701

	MAIL ADDRESS:	
		STREET 1:		822 A1A NORTH
		STREET 2:		SUITE 306
		CITY:			PONTE VEDRA
		STATE:			FL
		ZIP:			32082
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>